Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher W. Chiu
Survival Benefit With Proapoptotic Molecular and Pathologic Responses From Dual Targeting of Mammalian Target of Rapamycin and Epidermal Growth Factor Receptor in a Preclinical Model of Pancreatic Neuroendocrine Carcinogenesis
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck
Cancer Research
Cancer Research
Oncology
COX-2/sEH Dual Inhibitor PTUPB Suppresses Glioblastoma Growth by Targeting Epidermal Growth Factor Receptor and Hyaluronan Mediated Motility Receptor
Oncotarget
Oncology
Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1); Transforming Growth Factor-Β1 (TGFB1; TGFβ1)
Science-Business eXchange
Dual Inhibition of Both the Epidermal Growth Factor Receptor and erbB2 Effectively Inhibits the Promotion of Skin Tumors During Two-Stage Carcinogenesis
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging
Annals of the American Thoracic Society
Pulmonary
Respiratory Medicine
Understanding the Good and Poor Cell Targeting Activity of Gold Nanostructures Functionalized With Molecular Units for the Epidermal Growth Factor Receptor
Nanoscale Advances
Materials Science
Molecular Physics,
Engineering
Atomic
Bioengineering
Chemistry
Optics
Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance
PLoS ONE
Multidisciplinary
Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling
Molecular and Cellular Biology
Cell Biology
Molecular Biology
